Oncology Nursing Considerations in a Clinical Trials Environment

Legor, Kristen

doi:10.1016/j.soncn.2020.151020

Cited by 2 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Related serious adverse events, including death, have been reported (Casassus, 2016; Zhang et al, 2021). Furthermore, a clinical trial protocol involves several sections that will specifically outline the nursing care of subjects in a specific clinical trial (Legor, 2020), which varied from trial to trial as guidelines for nursing practice, so nurses had to keep learning.…”

Section: Discussionmentioning

confidence: 99%

Establishing an evaluation index system of nursing quality for clinical drug trials: A Delphi study

Chen,

Zhou,

Mai

et al. 2023

Nursing Open

View full text Add to dashboard Cite

AimsTo construct a quality evaluation index system for clinical drug trials nursing management and obtain the weight of all indicators.DesignA mixed‐method research design with a quantitative component was used, primarily qualitative.MethodsThrough a literature review and semi‐structured interview, an expert consultation questionnaire on the quality of nursing evaluation indicators for clinical drug trials was developed in April 2021. Eighteen experts in clinical drug trial nursing, medical, and pharmacy conducted 2 rounds of consultation according to the Delphi method to determine the indicators for evaluating the quality of clinical drug trial nursing. The weights of each indicator were determined using analytic hierarchical analysis.ResultsThe established quality evaluation system of clinical drug trial nursing mainly includes 3 first‐level indicators, 12 second‐level indicators, and 59 third‐level indicators. The positive coefficients of the two rounds of expert consultation were 90%–100%, and the authority coefficients were 0.831 and 0.885, respectively; the coordination coefficients were 0.189 and 0.214, respectively. The consulting results and weight settings are reliable. The evaluation index system we constructed is in line with the characteristics of the clinical drug trial nursing profession, with clear index levels and strong clinical operability, which can provide a reference for the assessment, monitoring and improvement of nursing quality in clinical drug trials. It will also clarify how nurses contribute to subjects' safety.

show abstract

Section: Discussionmentioning

confidence: 99%

Establishing an evaluation index system of nursing quality for clinical drug trials: A Delphi study

Chen,

Zhou,

Mai

et al. 2023

Nursing Open

View full text Add to dashboard Cite

show abstract

“…Clinical trial participation in the United States (US) has become more accessible through measures such as lessening financial barriers via the Clinical Treatment Act, which expands clinical trial reimbursements and benefits to those receiving Medicaid and Medicare support. As such, expanded access to trials has translated to the US enrolling the most clinical trial participants globally (one-third of all participants) and involved in the highest percentage of registered clinical trials 3 …”

mentioning

confidence: 99%

“…As such, expanded access to trials has translated to the US enrolling the most clinical trial participants globally (one-third of all participants) and involved in the highest percentage of registered clinical trials. 3 Clinical trial delivery models, which include decentralized and adaptive designs, permit the enrollment of individuals otherwise unable to participate in clinical trials due to travel burdens or inaccessibility due to geographic (rural or frontier) community settings. 4 Use of remote, virtual, and home health-based clinical trial services equates to a permeation of experimental drugs and devices into healthcare organizations and systems that may be unaware of a clinical trial's presence within a community.…”

mentioning

confidence: 99%

Clinical Nurses' Identification of a Wearable Universal Serial Bus Used for Pediatric Oncology Clinical Trial Participant Safety Management

Johnson

Rainbow

Carrington

2023

CIN: Computers, Informatics, Nursing

View full text Add to dashboard Cite

The expanded access to clinical trials has provided more patients the opportunity to participate in novel therapeutics research. There is an increased likelihood of a patient, as a pediatric oncology clinical trial participant, to present for clinical care outside the research site, such as at an emergency room or urgent care center. A novel wearable universal serial bus device is a proposed technology to bridge potential communication gaps, pertaining to critical information such as side effects and permitted therapies, between research teams and clinical teams where investigational agents may be contraindicated to standard treatments. Fifty-five emergency and urgent care nurses across the United States were presented, via online survey without priming to the context of clinical trials or the device, a picture of a pediatric patient wearing the novel wearable device prompted to identify significant, environmental cues important for patient care. Of the 40 nurses observing the patient photo, three identified the wearable device within Situational Awareness Global Assessment Tool formatted narrative response fields. Analysis of the narrative nurse-participant responses of significant clinical findings upon initial assessment of the pediatric patient photo is described, as well as the implications for subsequent prototyping of the novel universal serial bus prototype.

show abstract

Oncology Nursing Considerations in a Clinical Trials Environment

Cited by 2 publications

References 3 publications

Establishing an evaluation index system of nursing quality for clinical drug trials: A Delphi study

Establishing an evaluation index system of nursing quality for clinical drug trials: A Delphi study

Clinical Nurses' Identification of a Wearable Universal Serial Bus Used for Pediatric Oncology Clinical Trial Participant Safety Management

Contact Info

Product

Resources

About